Status:
COMPLETED
Prospective Evaluation of Femoral Tripod Eversion Technique
Lead Sponsor:
Hôpital NOVO
Conditions:
Atheromatous
Eligibility:
All Genders
18+ years
Brief Summary
Endarteriectomy is considered as the first line treatment of femoral bifurcation atheromatous lesions. Eversion technique, similar to that used for carotid bifurcation, is safe and possible for the ma...
Detailed Description
Femoral bifurcation lesions is one of the most frequent lesion encountered in lower limb atheromatous occlusive disease. Current treatment options consists in femoral endarteriectomy or bypass. More r...
Eligibility Criteria
Inclusion
- Age\>18 years
- Lower limb atheromatous occlusive disease.
- Stage 2 to 4 according to Rutherford's classification
Exclusion
- Age\< 18
- Previous surgery or endovascular treatment of the ipsilateral limb
- Non atheromatous disease
- Pregnancy
- Life-expectancy estimated to be less than one year
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2017
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT03357185
Start Date
June 1 2014
End Date
September 30 2017
Last Update
July 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.